Syngen Biotech Market Cap

Syngen Biotech has a market cap or net worth of 3.62 billion as of June 27, 2025. Its market cap has decreased by -10.40% in one year.

Market Cap

3.62B

Enterprise Value

3.64B

Revenue

2.03B

Ranking

n/a

PE Ratio

15.00

Stock Price

131.00

Market Cap Chart

Since November 2, 2004, Syngen Biotech's market cap has increased from 372.00M to 3.62B, an increase of 872.57%. That is a compound annual growth rate of 11.64%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	3.55B	3.15%
Dec 30, 2024	3.44B	-16.45%
Dec 29, 2023	4.12B	-6.17%
Dec 30, 2022	4.39B	43.36%
Dec 30, 2021	3.06B	4.63%
Dec 31, 2020	2.93B	-8.09%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	195.43B
PharmaEssentia	183.96B
Bora Pharmaceuticals Co., LTD.	83.99B
Lotus Pharmaceutical	57.85B
Oneness Biotech	31.37B
Polaris Group	30.28B
Center Laboratories	27.17B
TaiMed Biologics	25.54B

Market Cap Rankings